Literature DB >> 18314043

Regenerative medicine for tendinous and ligamentous injuries of sport horses.

Lisa A Fortier1, Roger K W Smith.   

Abstract

After tendon injury, the scar tissue that replaces the damaged tendon results in a substantial risk for reinjury. The goal of regenerative therapies is to restore normal structural architecture and biomechanical function to an injured tissue. Successful restoration processes for any tissue are thought to recapitulate those of development, in which there are spatial and temporal interactions between scaffold, growth factors, and cell populations.

Entities:  

Mesh：

Year:  2008        PMID： 18314043     DOI： 10.1016/j.cveq.2007.11.002

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN： 0749-0739            Impact factor:   1.792


  23 in total

1.  Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.

Authors:  Arianna Barbara Lovati; Bruna Corradetti; Anna Lange Consiglio; Camilla Recordati; Elisa Bonacina; Davide Bizzaro; Fausto Cremonesi
Journal:  Vet Res Commun       Date:  2010-12-31       Impact factor: 2.459

2.  Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells.

Authors:  Hayley M Lang; Lauren V Schnabel; Jennifer M Cassano; Lisa A Fortier
Journal:  Vet Surg       Date:  2017-03-22       Impact factor: 1.495

3.  The effects of bone marrow stromal cell transplants on tendon healing in vitro.

Authors:  Chunfeng Zhao; Hsiao-Feng Chieh; Karim Bakri; Jun Ikeda; Yu-Long Sun; Steven L Moran; Kai-Nan An; Peter C Amadio
Journal:  Med Eng Phys       Date:  2009-09-06       Impact factor: 2.242

4.  Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.

Authors:  Paola Torricelli; Milena Fini; Giuseppe Filardo; Matilde Tschon; Mario Pischedda; Alessandra Pacorini; Elizaveta Kon; Roberto Giardino
Journal:  Int Orthop       Date:  2011-03-11       Impact factor: 3.075

5.  Autologous conditioned plasma as therapy of tendon and ligament lesions in seven horses.

Authors:  Rindermann Georg; Cislakova Maria; Arndt Gisela; Carstanjen Bianca
Journal:  J Vet Sci       Date:  2010-06       Impact factor: 1.672

6.  Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().

Authors:  Danielle D Carrade; Michael W Lame; Michael S Kent; Kaitlin C Clark; Naomi J Walker; Dori L Borjesson
Journal:  Cell Med       Date:  2012-01-01

Review 7.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

Review 8.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

9.  Evaluation of early cellular influences of bone morphogenetic proteins 12 and 2 on equine superficial digital flexor tenocytes and bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Shannon J Murray; Kelly S Santangelo; Alicia L Bertone
Journal:  Am J Vet Res       Date:  2010-01       Impact factor: 1.156

Review 10.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.